Eledon Pharmaceuticals (ELDN) Q2 2026 Earnings

May 13Confirmed
Q2 2025
Q3 2025
Q4 2025
Q2 2026
-0.33
-0.25
-0.16
-0.08

Details

Expected EPS
-0.184
Actual EPS
-0.33
Surprise EPS
-0.15
Surprise Percent
-79.35%

Description

⁨Eledon Pharmaceuticals⁩ (⁦ELDN⁩) has reported earnings of ⁦-0.33⁩ per share for ⁦Q2 2026⁩.

0 Comments

Share your thoughts